{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"55.5","upperLimit":"85.0","value":"70.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"37"}],"units":"Participants"}],"title":"Pre-surgery"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"4.5","upperLimit":"28.8","value":"16.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"36"}],"units":"Participants"}],"title":"Post-surgery"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.0","upperLimit":"0.0","value":"0.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"27"}],"units":"Participants"}],"title":"Post-radiotherapy"}],"denoms":[{"counts":[{"groupId":"OG000","value":"37"}],"units":"Participants"}],"description":"Salivary gland functioning classified as \"Non-functioning\", \"Minimal function\", \"Well-functioning but some impairment\", \"Normal functioning\", or \"Other\" is determined by central review of scintigraphy scans using sodium pertechnetate (Na-99mTcO4-) with a sialagogue (lemon juice) administered halfway through the study to determine if secretory function is maintained.","dispersionType":"95% Confidence Interval","groups":[{"description":"Submandibular salivary gland transfer at the time of surgery for the primary tumor and neck nodes followed by post-operative radiation therapy.","id":"OG000","title":"Surgery + Transfer + Radiation"}],"paramType":"NUMBER","populationDescription":"Eligible patients with salivary scans submitted","reportingStatus":"POSTED","timeFrame":"Pre-surgery, post-surgery (4-6 weeks), post radiation therapy (10-13 weeks)","title":"Percentage of Patients With Normal Functioning Transferred Submandibular Gland","type":"SECONDARY","unitOfMeasure":"percentage of participants"}